img

Global Inactivated Porcine Atrophic Rhinitis Vaccine Market Insights, Forecast to 2034


Published on: 2024-01-04 | No of Pages : 400 | Industry : Agriculture

Publisher : MRA | Format : PDF

Global Inactivated Porcine Atrophic Rhinitis Vaccine Market Insights, Forecast to 2034

Market Analysis and InsightsGlobal Inactivated Porcine Atrophic Rhinitis Vaccine Market
The global Inactivated Porcine Atrophic Rhinitis Vaccine market is projected to grow from US$ million in 2023 to US$ million by 2033, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.
The US & Canada market for Inactivated Porcine Atrophic Rhinitis Vaccine is estimated to increase from $ million in 2023 to reach $ million by 2033, at a CAGR of % during the forecast period of 2023 through 2033.
The China market for Inactivated Porcine Atrophic Rhinitis Vaccine is estimated to increase from $ million in 2023 to reach $ million by 2033, at a CAGR of % during the forecast period of 2023 through 2033.
The Europe market for Inactivated Porcine Atrophic Rhinitis Vaccine is estimated to increase from $ million in 2023 to reach $ million by 2033, at a CAGR of % during the forecast period of 2023 through 2033.
The global key companies of Inactivated Porcine Atrophic Rhinitis Vaccine include Merck Animal Health, HIPRA, Bioveta, China Animal Husbandy Industry, Wuhan Keqian Biology, Pulike Bio-Engineering, Tiankang Animal Science Bio-Technology and Tianjin Ringpu Bio-Technology, etc. in 2022, the global top five players had a share approximately % in terms of revenue.
Report Includes
This report presents an overview of global market for Inactivated Porcine Atrophic Rhinitis Vaccine market size. Analyses of the global market trends, with historic market revenue data for 2018 - 2022, estimates for 2023, and projections of CAGR through 2033.
This report researches the key producers of Inactivated Porcine Atrophic Rhinitis Vaccine, also provides the revenue of main regions and countries. Highlights of the upcoming market potential for Inactivated Porcine Atrophic Rhinitis Vaccine, and key regions/countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the Inactivated Porcine Atrophic Rhinitis Vaccine revenue, market share and industry ranking of main companies, data from 2018 to 2023. Identification of the major stakeholders in the global Inactivated Porcine Atrophic Rhinitis Vaccine market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by type and by application, revenue, and growth rate, from 2018 to 2033. Evaluation and forecast the market size for Inactivated Porcine Atrophic Rhinitis Vaccine revenue, projected growth trends, production technology, application and end-user industry.
Descriptive company profiles of the major global players, including Merck Animal Health, HIPRA, Bioveta, China Animal Husbandy Industry, Wuhan Keqian Biology, Pulike Bio-Engineering, Tiankang Animal Science Bio-Technology and Tianjin Ringpu Bio-Technology, etc.



By Company


Merck Animal Health
HIPRA
Bioveta
China Animal Husbandy Industry
Wuhan Keqian Biology
Pulike Bio-Engineering
Tiankang Animal Science Bio-Technology
Tianjin Ringpu Bio-Technology
Segment by Type
Tissue Culture Origin
Cell Line Origin

Segment by Application


Sows
Gilts
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East, Africa, and Latin America
Turkey
Saudi Arabia
UAE
Rest of MEA

Chapter Outline


Chapter 1Introduces the report scope of the report, executive summary of different market segments (product type, application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2Revenue of Inactivated Porcine Atrophic Rhinitis Vaccine in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world. This section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3Detailed analysis of Inactivated Porcine Atrophic Rhinitis Vaccine companies’ competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6North America by type, by application and by country, revenue for each segment.
Chapter 7Europe by type, by application and by country, revenue for each segment.
Chapter 8China by type and by application revenue for each segment.
Chapter 9Asia (excluding China) by type, by application and by region, revenue for each segment.
Chapter 10Middle East, Africa, and Latin America by type, by application and by country, revenue for each segment.
Chapter 11Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Inactivated Porcine Atrophic Rhinitis Vaccine revenue, gross margin, and recent development, etc.
Chapter 12Analyst's Viewpoints/Conclusions

Table of Content

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Inactivated Porcine Atrophic Rhinitis Vaccine Market Size Growth Rate by Type, 2018 VS 2022 VS 2033
1.2.2 Tissue Culture Origin
1.2.3 Cell Line Origin
1.3 Market by Application
1.3.1 Global Inactivated Porcine Atrophic Rhinitis Vaccine Market Size Growth Rate by Application, 2018 VS 2022 VS 2033
1.3.2 Sows
1.3.3 Gilts
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Inactivated Porcine Atrophic Rhinitis Vaccine Market Perspective (2018-2033)
2.2 Global Inactivated Porcine Atrophic Rhinitis Vaccine Growth Trends by Region
2.2.1 Inactivated Porcine Atrophic Rhinitis Vaccine Market Size by Region: 2018 VS 2022 VS 2033
2.2.2 Inactivated Porcine Atrophic Rhinitis Vaccine Historic Market Size by Region (2018-2023)
2.2.3 Inactivated Porcine Atrophic Rhinitis Vaccine Forecasted Market Size by Region (2024-2033)
2.3 Inactivated Porcine Atrophic Rhinitis Vaccine Market Dynamics
2.3.1 Inactivated Porcine Atrophic Rhinitis Vaccine Industry Trends
2.3.2 Inactivated Porcine Atrophic Rhinitis Vaccine Market Drivers
2.3.3 Inactivated Porcine Atrophic Rhinitis Vaccine Market Challenges
2.3.4 Inactivated Porcine Atrophic Rhinitis Vaccine Market Restraints
3 Competition Landscape by Key Players
3.1 Global Revenue Inactivated Porcine Atrophic Rhinitis Vaccine by Players
3.1.1 Global Inactivated Porcine Atrophic Rhinitis Vaccine Revenue by Players (2018-2023)
3.1.2 Global Inactivated Porcine Atrophic Rhinitis Vaccine Revenue Market Share by Players (2018-2023)
3.2 Global Inactivated Porcine Atrophic Rhinitis Vaccine Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players of Inactivated Porcine Atrophic Rhinitis Vaccine, Ranking by Revenue, 2021 VS 2022 VS 2023
3.4 Global Inactivated Porcine Atrophic Rhinitis Vaccine Market Concentration Ratio
3.4.1 Global Inactivated Porcine Atrophic Rhinitis Vaccine Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Inactivated Porcine Atrophic Rhinitis Vaccine Revenue in 2022
3.5 Global Key Players of Inactivated Porcine Atrophic Rhinitis Vaccine Head office and Area Served
3.6 Global Key Players of Inactivated Porcine Atrophic Rhinitis Vaccine, Product and Application
3.7 Global Key Players of Inactivated Porcine Atrophic Rhinitis Vaccine, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Inactivated Porcine Atrophic Rhinitis Vaccine Breakdown Data by Type
4.1 Global Inactivated Porcine Atrophic Rhinitis Vaccine Historic Market Size by Type (2018-2023)
4.2 Global Inactivated Porcine Atrophic Rhinitis Vaccine Forecasted Market Size by Type (2024-2033)
5 Inactivated Porcine Atrophic Rhinitis Vaccine Breakdown Data by Application
5.1 Global Inactivated Porcine Atrophic Rhinitis Vaccine Historic Market Size by Application (2018-2023)
5.2 Global Inactivated Porcine Atrophic Rhinitis Vaccine Forecasted Market Size by Application (2024-2033)
6 North America
6.1 North America Inactivated Porcine Atrophic Rhinitis Vaccine Market Size (2018-2033)
6.2 North America Inactivated Porcine Atrophic Rhinitis Vaccine Market Size by Type
6.2.1 North America Inactivated Porcine Atrophic Rhinitis Vaccine Market Size by Type (2018-2023)
6.2.2 North America Inactivated Porcine Atrophic Rhinitis Vaccine Market Size by Type (2024-2033)
6.2.3 North America Inactivated Porcine Atrophic Rhinitis Vaccine Market Share by Type (2018-2033)
6.3 North America Inactivated Porcine Atrophic Rhinitis Vaccine Market Size by Application
6.3.1 North America Inactivated Porcine Atrophic Rhinitis Vaccine Market Size by Application (2018-2023)
6.3.2 North America Inactivated Porcine Atrophic Rhinitis Vaccine Market Size by Application (2024-2033)
6.3.3 North America Inactivated Porcine Atrophic Rhinitis Vaccine Market Share by Application (2018-2033)
6.4 North America Inactivated Porcine Atrophic Rhinitis Vaccine Market Size by Country
6.4.1 North America Inactivated Porcine Atrophic Rhinitis Vaccine Market Size by Country: 2018 VS 2022 VS 2033
6.4.2 North America Inactivated Porcine Atrophic Rhinitis Vaccine Market Size by Country (2018-2023)
6.4.3 North America Inactivated Porcine Atrophic Rhinitis Vaccine Market Size by Country (2024-2033)
6.4.4 United States
6.4.5 Canada
7 Europe
7.1 Europe Inactivated Porcine Atrophic Rhinitis Vaccine Market Size (2018-2033)
7.2 Europe Inactivated Porcine Atrophic Rhinitis Vaccine Market Size by Type
7.2.1 Europe Inactivated Porcine Atrophic Rhinitis Vaccine Market Size by Type (2018-2023)
7.2.2 Europe Inactivated Porcine Atrophic Rhinitis Vaccine Market Size by Type (2024-2033)
7.2.3 Europe Inactivated Porcine Atrophic Rhinitis Vaccine Market Share by Type (2018-2033)
7.3 Europe Inactivated Porcine Atrophic Rhinitis Vaccine Market Size by Application
7.3.1 Europe Inactivated Porcine Atrophic Rhinitis Vaccine Market Size by Application (2018-2023)
7.3.2 Europe Inactivated Porcine Atrophic Rhinitis Vaccine Market Size by Application (2024-2033)
7.3.3 Europe Inactivated Porcine Atrophic Rhinitis Vaccine Market Share by Application (2018-2033)
7.4 Europe Inactivated Porcine Atrophic Rhinitis Vaccine Market Size by Country
7.4.1 Europe Inactivated Porcine Atrophic Rhinitis Vaccine Market Size by Country: 2018 VS 2022 VS 2033
7.4.2 Europe Inactivated Porcine Atrophic Rhinitis Vaccine Market Size by Country (2018-2023)
7.4.3 Europe Inactivated Porcine Atrophic Rhinitis Vaccine Market Size by Country (2024-2033)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic Countries
8 China
8.1 China Inactivated Porcine Atrophic Rhinitis Vaccine Market Size (2018-2033)
8.2 China Inactivated Porcine Atrophic Rhinitis Vaccine Market Size by Type
8.2.1 China Inactivated Porcine Atrophic Rhinitis Vaccine Market Size by Type (2018-2023)
8.2.2 China Inactivated Porcine Atrophic Rhinitis Vaccine Market Size by Type (2024-2033)
8.2.3 China Inactivated Porcine Atrophic Rhinitis Vaccine Market Share by Type (2018-2033)
8.3 China Inactivated Porcine Atrophic Rhinitis Vaccine Market Size by Application
8.3.1 China Inactivated Porcine Atrophic Rhinitis Vaccine Market Size by Application (2018-2023)
8.3.2 China Inactivated Porcine Atrophic Rhinitis Vaccine Market Size by Application (2024-2033)
8.3.3 China Inactivated Porcine Atrophic Rhinitis Vaccine Market Share by Application (2018-2033)
9 Asia (excluding China)
9.1 Asia Inactivated Porcine Atrophic Rhinitis Vaccine Market Size (2018-2033)
9.2 Asia Inactivated Porcine Atrophic Rhinitis Vaccine Market Size by Type
9.2.1 Asia Inactivated Porcine Atrophic Rhinitis Vaccine Market Size by Type (2018-2023)
9.2.2 Asia Inactivated Porcine Atrophic Rhinitis Vaccine Market Size by Type (2024-2033)
9.2.3 Asia Inactivated Porcine Atrophic Rhinitis Vaccine Market Share by Type (2018-2033)
9.3 Asia Inactivated Porcine Atrophic Rhinitis Vaccine Market Size by Application
9.3.1 Asia Inactivated Porcine Atrophic Rhinitis Vaccine Market Size by Application (2018-2023)
9.3.2 Asia Inactivated Porcine Atrophic Rhinitis Vaccine Market Size by Application (2024-2033)
9.3.3 Asia Inactivated Porcine Atrophic Rhinitis Vaccine Market Share by Application (2018-2033)
9.4 Asia Inactivated Porcine Atrophic Rhinitis Vaccine Market Size by Region
9.4.1 Asia Inactivated Porcine Atrophic Rhinitis Vaccine Market Size by Region: 2018 VS 2022 VS 2033
9.4.2 Asia Inactivated Porcine Atrophic Rhinitis Vaccine Market Size by Region (2018-2023)
9.4.3 Asia Inactivated Porcine Atrophic Rhinitis Vaccine Market Size by Region (2024-2033)
9.4.4 Japan
9.4.5 South Korea
9.4.6 China Taiwan
9.4.7 Southeast Asia
9.4.8 India
9.4.9 Australia
10 Middle East, Africa, and Latin America
10.1 Middle East, Africa, and Latin America Inactivated Porcine Atrophic Rhinitis Vaccine Market Size (2018-2033)
10.2 Middle East, Africa, and Latin America Inactivated Porcine Atrophic Rhinitis Vaccine Market Size by Type
10.2.1 Middle East, Africa, and Latin America Inactivated Porcine Atrophic Rhinitis Vaccine Market Size by Type (2018-2023)
10.2.2 Middle East, Africa, and Latin America Inactivated Porcine Atrophic Rhinitis Vaccine Market Size by Type (2024-2033)
10.2.3 Middle East, Africa, and Latin America Inactivated Porcine Atrophic Rhinitis Vaccine Market Share by Type (2018-2033)
10.3 Middle East, Africa, and Latin America Inactivated Porcine Atrophic Rhinitis Vaccine Market Size by Application
10.3.1 Middle East, Africa, and Latin America Inactivated Porcine Atrophic Rhinitis Vaccine Market Size by Application (2018-2023)
10.3.2 Middle East, Africa, and Latin America Inactivated Porcine Atrophic Rhinitis Vaccine Market Size by Application (2024-2033)
10.3.3 Middle East, Africa, and Latin America Inactivated Porcine Atrophic Rhinitis Vaccine Market Share by Application (2018-2033)
10.4 Middle East, Africa, and Latin America Inactivated Porcine Atrophic Rhinitis Vaccine Market Size by Country
10.4.1 Middle East, Africa, and Latin America Inactivated Porcine Atrophic Rhinitis Vaccine Market Size by Country: 2018 VS 2022 VS 2033
10.4.2 Middle East, Africa, and Latin America Inactivated Porcine Atrophic Rhinitis Vaccine Market Size by Country (2018-2023)
10.4.3 Middle East, Africa, and Latin America Inactivated Porcine Atrophic Rhinitis Vaccine Market Size by Country (2024-2033)
10.4.4 Brazil
10.4.5 Mexico
10.4.6 Turkey
10.4.7 Saudi Arabia
10.4.8 Israel
10.4.9 GCC Countries
11 Key Players Profiles
11.1 Merck Animal Health
11.1.1 Merck Animal Health Company Details
11.1.2 Merck Animal Health Business Overview
11.1.3 Merck Animal Health Inactivated Porcine Atrophic Rhinitis Vaccine Introduction
11.1.4 Merck Animal Health Revenue in Inactivated Porcine Atrophic Rhinitis Vaccine Business (2018-2023)
11.1.5 Merck Animal Health Recent Developments
11.2 HIPRA
11.2.1 HIPRA Company Details
11.2.2 HIPRA Business Overview
11.2.3 HIPRA Inactivated Porcine Atrophic Rhinitis Vaccine Introduction
11.2.4 HIPRA Revenue in Inactivated Porcine Atrophic Rhinitis Vaccine Business (2018-2023)
11.2.5 HIPRA Recent Developments
11.3 Bioveta
11.3.1 Bioveta Company Details
11.3.2 Bioveta Business Overview
11.3.3 Bioveta Inactivated Porcine Atrophic Rhinitis Vaccine Introduction
11.3.4 Bioveta Revenue in Inactivated Porcine Atrophic Rhinitis Vaccine Business (2018-2023)
11.3.5 Bioveta Recent Developments
11.4 China Animal Husbandy Industry
11.4.1 China Animal Husbandy Industry Company Details
11.4.2 China Animal Husbandy Industry Business Overview
11.4.3 China Animal Husbandy Industry Inactivated Porcine Atrophic Rhinitis Vaccine Introduction
11.4.4 China Animal Husbandy Industry Revenue in Inactivated Porcine Atrophic Rhinitis Vaccine Business (2018-2023)
11.4.5 China Animal Husbandy Industry Recent Developments
11.5 Wuhan Keqian Biology
11.5.1 Wuhan Keqian Biology Company Details
11.5.2 Wuhan Keqian Biology Business Overview
11.5.3 Wuhan Keqian Biology Inactivated Porcine Atrophic Rhinitis Vaccine Introduction
11.5.4 Wuhan Keqian Biology Revenue in Inactivated Porcine Atrophic Rhinitis Vaccine Business (2018-2023)
11.5.5 Wuhan Keqian Biology Recent Developments
11.6 Pulike Bio-Engineering
11.6.1 Pulike Bio-Engineering Company Details
11.6.2 Pulike Bio-Engineering Business Overview
11.6.3 Pulike Bio-Engineering Inactivated Porcine Atrophic Rhinitis Vaccine Introduction
11.6.4 Pulike Bio-Engineering Revenue in Inactivated Porcine Atrophic Rhinitis Vaccine Business (2018-2023)
11.6.5 Pulike Bio-Engineering Recent Developments
11.7 Tiankang Animal Science Bio-Technology
11.7.1 Tiankang Animal Science Bio-Technology Company Details
11.7.2 Tiankang Animal Science Bio-Technology Business Overview
11.7.3 Tiankang Animal Science Bio-Technology Inactivated Porcine Atrophic Rhinitis Vaccine Introduction
11.7.4 Tiankang Animal Science Bio-Technology Revenue in Inactivated Porcine Atrophic Rhinitis Vaccine Business (2018-2023)
11.7.5 Tiankang Animal Science Bio-Technology Recent Developments
11.8 Tianjin Ringpu Bio-Technology
11.8.1 Tianjin Ringpu Bio-Technology Company Details
11.8.2 Tianjin Ringpu Bio-Technology Business Overview
11.8.3 Tianjin Ringpu Bio-Technology Inactivated Porcine Atrophic Rhinitis Vaccine Introduction
11.8.4 Tianjin Ringpu Bio-Technology Revenue in Inactivated Porcine Atrophic Rhinitis Vaccine Business (2018-2023)
11.8.5 Tianjin Ringpu Bio-Technology Recent Developments
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Figure

List of Tables
Table 1. Global Inactivated Porcine Atrophic Rhinitis Vaccine Market Size Growth Rate by Type (US$ Million), 2018 VS 2022 VS 2033
Table 2. Key Players of Tissue Culture Origin
Table 3. Key Players of Cell Line Origin
Table 4. Global Inactivated Porcine Atrophic Rhinitis Vaccine Market Size Growth Rate by Application (US$ Million), 2018 VS 2022 VS 2033
Table 5. Global Inactivated Porcine Atrophic Rhinitis Vaccine Market Size Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2022 VS 2033
Table 6. Global Inactivated Porcine Atrophic Rhinitis Vaccine Market Size by Region (2018-2023) & (US$ Million)
Table 7. Global Inactivated Porcine Atrophic Rhinitis Vaccine Market Share by Region (2018-2023)
Table 8. Global Inactivated Porcine Atrophic Rhinitis Vaccine Forecasted Market Size by Region (2024-2033) & (US$ Million)
Table 9. Global Inactivated Porcine Atrophic Rhinitis Vaccine Market Share by Region (2024-2033)
Table 10. Inactivated Porcine Atrophic Rhinitis Vaccine Market Trends
Table 11. Inactivated Porcine Atrophic Rhinitis Vaccine Market Drivers
Table 12. Inactivated Porcine Atrophic Rhinitis Vaccine Market Challenges
Table 13. Inactivated Porcine Atrophic Rhinitis Vaccine Market Restraints
Table 14. Global Inactivated Porcine Atrophic Rhinitis Vaccine Revenue by Players (2018-2023) & (US$ Million)
Table 15. Global Inactivated Porcine Atrophic Rhinitis Vaccine Revenue Share by Players (2018-2023)
Table 16. Global Top Inactivated Porcine Atrophic Rhinitis Vaccine by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Inactivated Porcine Atrophic Rhinitis Vaccine as of 2022)
Table 17. Global Inactivated Porcine Atrophic Rhinitis Vaccine Industry Ranking 2021 VS 2022 VS 2023
Table 18. Global 5 Largest Players Market Share by Inactivated Porcine Atrophic Rhinitis Vaccine Revenue (CR5 and HHI) & (2018-2023)
Table 19. Global Key Players of Inactivated Porcine Atrophic Rhinitis Vaccine, Headquarters and Area Served
Table 20. Global Key Players of Inactivated Porcine Atrophic Rhinitis Vaccine, Product and Application
Table 21. Global Key Players of Inactivated Porcine Atrophic Rhinitis Vaccine, Product and Application
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global Inactivated Porcine Atrophic Rhinitis Vaccine Market Size by Type (2018-2023) & (US$ Million)
Table 24. Global Inactivated Porcine Atrophic Rhinitis Vaccine Revenue Market Share by Type (2018-2023)
Table 25. Global Inactivated Porcine Atrophic Rhinitis Vaccine Forecasted Market Size by Type (2024-2033) & (US$ Million)
Table 26. Global Inactivated Porcine Atrophic Rhinitis Vaccine Revenue Market Share by Type (2024-2033)
Table 27. Global Inactivated Porcine Atrophic Rhinitis Vaccine Market Size by Application (2018-2023) & (US$ Million)
Table 28. Global Inactivated Porcine Atrophic Rhinitis Vaccine Revenue Share by Application (2018-2023)
Table 29. Global Inactivated Porcine Atrophic Rhinitis Vaccine Forecasted Market Size by Application (2024-2033) & (US$ Million)
Table 30. Global Inactivated Porcine Atrophic Rhinitis Vaccine Revenue Share by Application (2024-2033)
Table 31. North America Inactivated Porcine Atrophic Rhinitis Vaccine Market Size by Type (2018-2023) & (US$ Million)
Table 32. North America Inactivated Porcine Atrophic Rhinitis Vaccine Market Size by Type (2024-2033) & (US$ Million)
Table 33. North America Inactivated Porcine Atrophic Rhinitis Vaccine Market Size by Application (2018-2023) & (US$ Million)
Table 34. North America Inactivated Porcine Atrophic Rhinitis Vaccine Market Size by Application (2024-2033) & (US$ Million)
Table 35. North America Inactivated Porcine Atrophic Rhinitis Vaccine Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2033
Table 36. North America Inactivated Porcine Atrophic Rhinitis Vaccine Market Size by Country (2018-2023) & (US$ Million)
Table 37. North America Inactivated Porcine Atrophic Rhinitis Vaccine Market Size by Country (2024-2033) & (US$ Million)
Table 38. Europe Inactivated Porcine Atrophic Rhinitis Vaccine Market Size by Type (2018-2023) & (US$ Million)
Table 39. Europe Inactivated Porcine Atrophic Rhinitis Vaccine Market Size by Type (2024-2033) & (US$ Million)
Table 40. Europe Inactivated Porcine Atrophic Rhinitis Vaccine Market Size by Application (2018-2023) & (US$ Million)
Table 41. Europe Inactivated Porcine Atrophic Rhinitis Vaccine Market Size by Application (2024-2033) & (US$ Million)
Table 42. Europe Inactivated Porcine Atrophic Rhinitis Vaccine Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2033
Table 43. Europe Inactivated Porcine Atrophic Rhinitis Vaccine Market Size by Country (2018-2023) & (US$ Million)
Table 44. Europe Inactivated Porcine Atrophic Rhinitis Vaccine Market Size by Country (2024-2033) & (US$ Million)
Table 45. China Inactivated Porcine Atrophic Rhinitis Vaccine Market Size by Type (2018-2023) & (US$ Million)
Table 46. China Inactivated Porcine Atrophic Rhinitis Vaccine Market Size by Type (2024-2033) & (US$ Million)
Table 47. China Inactivated Porcine Atrophic Rhinitis Vaccine Market Size by Application (2018-2023) & (US$ Million)
Table 48. China Inactivated Porcine Atrophic Rhinitis Vaccine Market Size by Application (2024-2033) & (US$ Million)
Table 49. Asia Inactivated Porcine Atrophic Rhinitis Vaccine Market Size by Type (2018-2023) & (US$ Million)
Table 50. Asia Inactivated Porcine Atrophic Rhinitis Vaccine Market Size by Type (2024-2033) & (US$ Million)
Table 51. Asia Inactivated Porcine Atrophic Rhinitis Vaccine Market Size by Application (2018-2023) & (US$ Million)
Table 52. Asia Inactivated Porcine Atrophic Rhinitis Vaccine Market Size by Application (2024-2033) & (US$ Million)
Table 53. Asia Inactivated Porcine Atrophic Rhinitis Vaccine Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2022 VS 2033
Table 54. Asia Inactivated Porcine Atrophic Rhinitis Vaccine Market Size by Region (2018-2023) & (US$ Million)
Table 55. Asia Inactivated Porcine Atrophic Rhinitis Vaccine Market Size by Region (2024-2033) & (US$ Million)
Table 56. Middle East, Africa, and Latin America Inactivated Porcine Atrophic Rhinitis Vaccine Market Size by Type (2018-2023) & (US$ Million)
Table 57. Middle East, Africa, and Latin America Inactivated Porcine Atrophic Rhinitis Vaccine Market Size by Type (2024-2033) & (US$ Million)
Table 58. Middle East, Africa, and Latin America Inactivated Porcine Atrophic Rhinitis Vaccine Market Size by Application (2018-2023) & (US$ Million)
Table 59. Middle East, Africa, and Latin America Inactivated Porcine Atrophic Rhinitis Vaccine Market Size by Application (2024-2033) & (US$ Million)
Table 60. Middle East, Africa, and Latin America Inactivated Porcine Atrophic Rhinitis Vaccine Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2033
Table 61. Middle East, Africa, and Latin America Inactivated Porcine Atrophic Rhinitis Vaccine Market Size by Country (2018-2023) & (US$ Million)
Table 62. Middle East, Africa, and Latin America Inactivated Porcine Atrophic Rhinitis Vaccine Market Size by Country (2024-2033) & (US$ Million)
Table 63. Merck Animal Health Company Details
Table 64. Merck Animal Health Business Overview
Table 65. Merck Animal Health Inactivated Porcine Atrophic Rhinitis Vaccine Product
Table 66. Merck Animal Health Revenue in Inactivated Porcine Atrophic Rhinitis Vaccine Business (2018-2023) & (US$ Million)
Table 67. Merck Animal Health Recent Developments
Table 68. HIPRA Company Details
Table 69. HIPRA Business Overview
Table 70. HIPRA Inactivated Porcine Atrophic Rhinitis Vaccine Product
Table 71. HIPRA Revenue in Inactivated Porcine Atrophic Rhinitis Vaccine Business (2018-2023) & (US$ Million)
Table 72. HIPRA Recent Developments
Table 73. Bioveta Company Details
Table 74. Bioveta Business Overview
Table 75. Bioveta Inactivated Porcine Atrophic Rhinitis Vaccine Product
Table 76. Bioveta Revenue in Inactivated Porcine Atrophic Rhinitis Vaccine Business (2018-2023) & (US$ Million)
Table 77. Bioveta Recent Developments
Table 78. China Animal Husbandy Industry Company Details
Table 79. China Animal Husbandy Industry Business Overview
Table 80. China Animal Husbandy Industry Inactivated Porcine Atrophic Rhinitis Vaccine Product
Table 81. China Animal Husbandy Industry Revenue in Inactivated Porcine Atrophic Rhinitis Vaccine Business (2018-2023) & (US$ Million)
Table 82. China Animal Husbandy Industry Recent Developments
Table 83. Wuhan Keqian Biology Company Details
Table 84. Wuhan Keqian Biology Business Overview
Table 85. Wuhan Keqian Biology Inactivated Porcine Atrophic Rhinitis Vaccine Product
Table 86. Wuhan Keqian Biology Revenue in Inactivated Porcine Atrophic Rhinitis Vaccine Business (2018-2023) & (US$ Million)
Table 87. Wuhan Keqian Biology Recent Developments
Table 88. Pulike Bio-Engineering Company Details
Table 89. Pulike Bio-Engineering Business Overview
Table 90. Pulike Bio-Engineering Inactivated Porcine Atrophic Rhinitis Vaccine Product
Table 91. Pulike Bio-Engineering Revenue in Inactivated Porcine Atrophic Rhinitis Vaccine Business (2018-2023) & (US$ Million)
Table 92. Pulike Bio-Engineering Recent Developments
Table 93. Tiankang Animal Science Bio-Technology Company Details
Table 94. Tiankang Animal Science Bio-Technology Business Overview
Table 95. Tiankang Animal Science Bio-Technology Inactivated Porcine Atrophic Rhinitis Vaccine Product
Table 96. Tiankang Animal Science Bio-Technology Revenue in Inactivated Porcine Atrophic Rhinitis Vaccine Business (2018-2023) & (US$ Million)
Table 97. Tiankang Animal Science Bio-Technology Recent Developments
Table 98. Tianjin Ringpu Bio-Technology Company Details
Table 99. Tianjin Ringpu Bio-Technology Business Overview
Table 100. Tianjin Ringpu Bio-Technology Inactivated Porcine Atrophic Rhinitis Vaccine Product
Table 101. Tianjin Ringpu Bio-Technology Revenue in Inactivated Porcine Atrophic Rhinitis Vaccine Business (2018-2023) & (US$ Million)
Table 102. Tianjin Ringpu Bio-Technology Recent Developments
Table 103. Research Programs/Design for This Report
Table 104. Key Data Information from Secondary Sources
Table 105. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Inactivated Porcine Atrophic Rhinitis Vaccine Market Size Growth Rate by Type, 2018 VS 2022 VS 2033 (US$ Million)
Figure 2. Global Inactivated Porcine Atrophic Rhinitis Vaccine Market Share by Type: 2022 VS 2033
Figure 3. Tissue Culture Origin Features
Figure 4. Cell Line Origin Features
Figure 5. Global Inactivated Porcine Atrophic Rhinitis Vaccine Market Size Growth Rate by Application, 2018 VS 2022 VS 2033 (US$ Million)
Figure 6. Global Inactivated Porcine Atrophic Rhinitis Vaccine Market Share by Application: 2022 VS 2033
Figure 7. Sows Case Studies
Figure 8. Gilts Case Studies
Figure 9. Inactivated Porcine Atrophic Rhinitis Vaccine Report Years Considered
Figure 10. Global Inactivated Porcine Atrophic Rhinitis Vaccine Market Size (US$ Million), Year-over-Year: 2018-2033
Figure 11. Global Inactivated Porcine Atrophic Rhinitis Vaccine Market Size, (US$ Million), 2018 VS 2022 VS 2033
Figure 12. Global Inactivated Porcine Atrophic Rhinitis Vaccine Market Share by Region: 2022 VS 2033
Figure 13. Global Inactivated Porcine Atrophic Rhinitis Vaccine Market Share by Players in 2022
Figure 14. Global Top Inactivated Porcine Atrophic Rhinitis Vaccine Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Inactivated Porcine Atrophic Rhinitis Vaccine as of 2022)
Figure 15. The Top 10 and 5 Players Market Share by Inactivated Porcine Atrophic Rhinitis Vaccine Revenue in 2022
Figure 16. North America Inactivated Porcine Atrophic Rhinitis Vaccine Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 17. North America Inactivated Porcine Atrophic Rhinitis Vaccine Market Share by Type (2018-2033)
Figure 18. North America Inactivated Porcine Atrophic Rhinitis Vaccine Market Share by Application (2018-2033)
Figure 19. North America Inactivated Porcine Atrophic Rhinitis Vaccine Market Share by Country (2018-2033)
Figure 20. United States Inactivated Porcine Atrophic Rhinitis Vaccine Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 21. Canada Inactivated Porcine Atrophic Rhinitis Vaccine Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 22. Europe Inactivated Porcine Atrophic Rhinitis Vaccine Market Size YoY (2018-2033) & (US$ Million)
Figure 23. Europe Inactivated Porcine Atrophic Rhinitis Vaccine Market Share by Type (2018-2033)
Figure 24. Europe Inactivated Porcine Atrophic Rhinitis Vaccine Market Share by Application (2018-2033)
Figure 25. Europe Inactivated Porcine Atrophic Rhinitis Vaccine Market Share by Country (2018-2033)
Figure 26. Germany Inactivated Porcine Atrophic Rhinitis Vaccine Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 27. France Inactivated Porcine Atrophic Rhinitis Vaccine Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 28. U.K. Inactivated Porcine Atrophic Rhinitis Vaccine Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 29. Italy Inactivated Porcine Atrophic Rhinitis Vaccine Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 30. Russia Inactivated Porcine Atrophic Rhinitis Vaccine Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 31. Nordic Countries Inactivated Porcine Atrophic Rhinitis Vaccine Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 32. China Inactivated Porcine Atrophic Rhinitis Vaccine Market Size YoY (2018-2033) & (US$ Million)
Figure 33. China Inactivated Porcine Atrophic Rhinitis Vaccine Market Share by Type (2018-2033)
Figure 34. China Inactivated Porcine Atrophic Rhinitis Vaccine Market Share by Application (2018-2033)
Figure 35. Asia Inactivated Porcine Atrophic Rhinitis Vaccine Market Size YoY (2018-2033) & (US$ Million)
Figure 36. Asia Inactivated Porcine Atrophic Rhinitis Vaccine Market Share by Type (2018-2033)
Figure 37. Asia Inactivated Porcine Atrophic Rhinitis Vaccine Market Share by Application (2018-2033)
Figure 38. Asia Inactivated Porcine Atrophic Rhinitis Vaccine Market Share by Region (2018-2033)
Figure 39. Japan Inactivated Porcine Atrophic Rhinitis Vaccine Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 40. South Korea Inactivated Porcine Atrophic Rhinitis Vaccine Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 41. China Taiwan Inactivated Porcine Atrophic Rhinitis Vaccine Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 42. Southeast Asia Inactivated Porcine Atrophic Rhinitis Vaccine Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 43. India Inactivated Porcine Atrophic Rhinitis Vaccine Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 44. Australia Inactivated Porcine Atrophic Rhinitis Vaccine Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 45. Middle East, Africa, and Latin America Inactivated Porcine Atrophic Rhinitis Vaccine Market Size YoY (2018-2033) & (US$ Million)
Figure 46. Middle East, Africa, and Latin America Inactivated Porcine Atrophic Rhinitis Vaccine Market Share by Type (2018-2033)
Figure 47. Middle East, Africa, and Latin America Inactivated Porcine Atrophic Rhinitis Vaccine Market Share by Application (2018-2033)
Figure 48. Middle East, Africa, and Latin America Inactivated Porcine Atrophic Rhinitis Vaccine Market Share by Country (2018-2033)
Figure 49. Brazil Inactivated Porcine Atrophic Rhinitis Vaccine Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 50. Mexico Inactivated Porcine Atrophic Rhinitis Vaccine Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 51. Turkey Inactivated Porcine Atrophic Rhinitis Vaccine Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 52. Saudi Arabia Inactivated Porcine Atrophic Rhinitis Vaccine Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 53. Israel Inactivated Porcine Atrophic Rhinitis Vaccine Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 54. GCC Countries Inactivated Porcine Atrophic Rhinitis Vaccine Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 55. Merck Animal Health Revenue Growth Rate in Inactivated Porcine Atrophic Rhinitis Vaccine Business (2018-2023)
Figure 56. HIPRA Revenue Growth Rate in Inactivated Porcine Atrophic Rhinitis Vaccine Business (2018-2023)
Figure 57. Bioveta Revenue Growth Rate in Inactivated Porcine Atrophic Rhinitis Vaccine Business (2018-2023)
Figure 58. China Animal Husbandy Industry Revenue Growth Rate in Inactivated Porcine Atrophic Rhinitis Vaccine Business (2018-2023)
Figure 59. Wuhan Keqian Biology Revenue Growth Rate in Inactivated Porcine Atrophic Rhinitis Vaccine Business (2018-2023)
Figure 60. Pulike Bio-Engineering Revenue Growth Rate in Inactivated Porcine Atrophic Rhinitis Vaccine Business (2018-2023)
Figure 61. Tiankang Animal Science Bio-Technology Revenue Growth Rate in Inactivated Porcine Atrophic Rhinitis Vaccine Business (2018-2023)
Figure 62. Tianjin Ringpu Bio-Technology Revenue Growth Rate in Inactivated Porcine Atrophic Rhinitis Vaccine Business (2018-2023)
Figure 63. Bottom-up and Top-down Approaches for This Report
Figure 64. Data Triangulation
Figure 65. Key Executives Interviewed